Raia Drogasil S.A. (RADLY)
OTCMKTS · Delayed Price · Currency is USD
3.875
+0.165 (4.45%)
Nov 6, 2025, 1:29 PM EST
Raia Drogasil Revenue
Raia Drogasil had revenue of 11.26B BRL in the quarter ending September 30, 2025, with 12.77% growth. This brings the company's revenue in the last twelve months to 42.24B, up 12.04% year-over-year. In the year 2024, Raia Drogasil had annual revenue of 38.86B with 14.40% growth.
Revenue (ttm)
42.24B BRL
Revenue Growth
+12.04%
P/S Ratio
0.81
Revenue / Employee
652.30K BRL
Employees
64,758
Market Cap
6.45B USD
Revenue Chart
* This company reports financials in BRL.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 38.86B | 4.89B | 14.40% |
| Dec 31, 2023 | 33.97B | 4.91B | 16.88% |
| Dec 31, 2022 | 29.07B | 4.94B | 20.48% |
| Dec 31, 2021 | 24.13B | 4.06B | 20.23% |
| Dec 31, 2020 | 20.07B | 2.50B | 14.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| China New Energy Group Co. | 12.51M |
| Nuo Therapeutics | 2.61M |
Raia Drogasil News
- 1 day ago - Raia Drogasil S.A. reports Q3 results - Seeking Alpha
- 1 day ago - Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 6 months ago - Raia Drogasil: Valuation Burn Now, Healthy Gains Later - Seeking Alpha
- 8 months ago - Raia Drogasil SA (RADLY) Q4 2024 Earnings Call Highlights: Expansion and Digital Growth Amid ... - GuruFocus
- 11 months ago - Raia Drogasil S.A. goes ex dividend tomorrow - Seeking Alpha
- 1 year ago - Raia Drogasil goes ex dividend tomorrow - Seeking Alpha